Display options
Share it on

NDT Plus. 2011 Apr;4(2):87-9. doi: 10.1093/ndtplus/sfr002. Epub 2011 Feb 24.

High-dose continuous venovenous hemofiltration combined with charcoal hemoperfusion for methotrexate removal.

NDT plus

Carrie Grafft, Heidi Gunderson, Loralie Langman, Joseph C Farmer, Nelson Leung

Affiliations

  1. Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN, USA.
  2. Department of Pharmacy, Mayo Clinic, Rochester, MN, USA.
  3. Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
  4. Division of Critical Care, Mayo Clinic, Rochester, MN, USA.

PMID: 25984119 PMCID: PMC4421587 DOI: 10.1093/ndtplus/sfr002

[No abstract available.]

References

  1. Curr Opin Crit Care. 2007 Dec;13(6):668-73 - PubMed
  2. Br J Cancer. 2005 Feb 14;92(3):480-7 - PubMed
  3. Cancer. 1988 Sep 1;62(5):884-8 - PubMed
  4. Semin Dial. 2006 Sep-Oct;19(5):402-7 - PubMed
  5. Contrib Nephrol. 1995;116:48-52 - PubMed
  6. Oncologist. 2007 Nov;12(11):1299-308 - PubMed
  7. N Engl J Med. 1983 Nov 3;309(18):1094-104 - PubMed
  8. Nephron. 1989;51(3):416-7 - PubMed
  9. Am J Med. 1987 Feb;82(2):350-2 - PubMed
  10. Oncologist. 2006 Jun;11(6):694-703 - PubMed

Publication Types